GNPX
GENPREX (GNPX)
NASDAQ
$0.74+$0.003 (+0.38%)
Price as of Jun 03, 2026 7:04 PM EDT
  • $8.3M
    Market Cap
  • -94.87%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
-299
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-299
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-9.4M
-10.50%
-10.5M
-40.20%
-17.6M
+53.05%
-11.5M
+33.72%
Depreciation and Amortization Expense
0
-100.00%
773,478
+5,055.15%
15,004
-41.33%
25,575
+13.50%
Total Operating Expenses
0
-100.00%
21.2M
-31.86%
31.1M
+30.40%
23.8M
+21.58%
Operating Profit
-15.5M
-26.72%
-21.2M
-31.86%
-31.1M
+30.40%
-23.8M
+21.58%
Interest Income
26,900
-57.69%
63,574
-70.45%
215,109
+138.75%
90,098
+1,655.27%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
26,900
-57.69%
63,574
-70.45%
215,109
+138.75%
90,098
+1,655.27%
Total Nonoperating Income and Expense
26,900
N/A
0
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-16.2M
-24.12%
-21.4M
-31.17%
-31.1M
+30.40%
-23.8M
+21.58%
Income Taxes
0
-100.00%
2,650
N/A
0
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-16.2M
-23.13%
-21.1M
-31.59%
-30.9M
+29.99%
-23.7M
+21.15%
Net Income from Continuing Operations Applicable to Common
-16.2M
-24.12%
-21.4M
-30.69%
-30.9M
+29.99%
-23.7M
+21.15%
Basic EPS and Net Income
-17.40
+225.84%
-5.34
-76.33%
-22.56
+4,412.00%
-0.50
+19.05%
Diluted EPS and Net Income
-17.40
+225.84%
-5.34
-76.33%
-22.56
+4,412.00%
-0.50
+19.05%
Basic Weighted Average Shares
932,730
-76.72%
4.0M
+192.89%
1.4M
-97.15%
48.0M
+1.82%
Diluted Weighted Average Shares
932,730
-76.72%
4.0M
+192.89%
1.4M
-97.15%
48.0M
+1.82%
Balance Sheet
Cash and Cash Equivalents
7.8M
+388.92%
1.6M
-76.23%
6.7M
-67.85%
21.0M
-45.76%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.8M
+388.92%
1.6M
-76.23%
6.7M
-67.85%
21.0M
-45.76%
Total Current Assets
8.4M
+302.26%
2.1M
-72.42%
7.5M
-64.92%
21.5M
-45.14%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
0
N/A
0
-100.00%
7,859
-65.88%
23,032
-52.62%
Total Long-Term Assets
1.8M
-11.95%
2.0M
-34.63%
3.1M
-12.76%
3.6M
-2.30%
Total Assets
10.2M
+146.32%
4.1M
-61.35%
10.7M
-57.46%
25.1M
-41.48%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.2M
-13.16%
2.5M
-23.05%
3.3M
+15.80%
2.8M
+77.27%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
22,500
-91.88%
277,119
N/A
N/A
N/A
N/A
N/A
Total Liabilities
2.2M
-12.26%
2.5M
-23.05%
3.3M
+15.80%
2.8M
+77.27%
Retained Earnings
-171.0M
+10.48%
-154.8M
+15.79%
-133.7M
+30.01%
-102.8M
+31.80%
Total Stockholders Equity
8.0M
+391.43%
1.6M
-78.15%
7.4M
-66.70%
22.3M
-46.04%
Total Shares Outstanding
3.3M
-69.69%
10.9M
+630.91%
1.5M
-96.91%
48.1M
+0.48%
Cash Flow
Cash from Operating Activities
-15.3M
-10.72%
-17.1M
-30.68%
-24.7M
+39.15%
-17.8M
+24.46%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Cash from Investing Activities
0
-100.00%
1,166
+101.64%
-71,214
-172.87%
97,731
+216.63%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
21.5M
+79.32%
12.0M
+13.39%
10.6M
+164,751.81%
6,426
-99.97%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
5,189,170.23%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-227.24%
-20.37%
-285.38%
+65.33%
-172.62%
+147.02%
-69.88%
+32.35%
Return on Equity
-338.74%
-27.50%
-467.24%
+124.77%
-207.88%
+178.23%
-74.71%
+37.63%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.84
+363.21%
0.83
-64.16%
2.31
-69.71%
7.64
-69.05%
Cash Ratio
3.60
+463.01%
0.64
-69.11%
2.07
-72.23%
7.46
-69.40%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow